Estimating the hospital costs of care for people living with HIV in England using routinely collected data
HIV Medicine · 2023
DOI: 10.1111/hiv.13529 ↗Kurz gefasst
Fachartikel in der Zeitschrift HIV Medicine, 2023. Verfasst von Alec Miners und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK. Hauptthemen laut MEDLINE: HIV Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Institute for Health Research (NIHR).
Abstract (Originalsprache)
Background
Understanding the health care activity and associated hospital costs of caring for people living with HIV is an important component of assessing the cost effectiveness of new technologies and for budget planning.
Methods
Data collected between 2010 and 2017 from an English HIV treatment centre were combined with national reference costs to estimate the rate of hospital attendances and costs per quarter year, according to demographic and clinical factors. The final dataset included records for 1763 people living with HIV, which was analysed using negative binomial regression models and general estimating equations.
Results
People living with HIV experienced an unadjusted average of 0.028 (standard deviation [SD] 0.20) inpatient episodes per quarter, equivalent to one every 9 years, and 1.85 (SD 2.30) outpatient visits per quarter. The unadjusted mean quarterly cost per person with HIV (excluding antiretroviral drug costs) was £439 (SD 604). Outpatient appointments and inpatient episodes accounted for 88% and 6% of total costs, respectively. In adjusted models, low CD4 count was the strongest predictor of inpatient stays and outpatient visits. Low CD4 count and new patient status (having a first visit at the Trust in the last 6 months) were the factors that most increased estimated costs. Associations were weaker or less consistent for demographic factors (age, sex/sexual orientation/ethnicity). Sensitivity analyses suggest that the findings were generally robust to alternative parameter and modelling assumptions.
Conclusion
A number of factors predicted hospital activity and costs, but CD4 cell count and new patient status were the strongest. The study results can be incorporated into future economic evaluations and budget impact assessments of HIV‐related technologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.
- Institute for Global Health, University College London, London, UK.
- North London Partners in Health and Care, London, UK.
- UK Health Security Agency, London, UK.
ORCID-Profile: Alec Miners, Fiona C Lampe, Valentina Cambiano, Alison Rodger, Zia Sadique, Sophia Rein, Valerie Delpech, Andrew N Phillips
Förderung
- the National Institute for Health Research (NIHR)
Zitieren
APA
Miners, A., Lampe, F. C., Cambiano, V., Schwenk, A., Rodger, A., Sadique, Z., Rein, S., Delpech, V., & Phillips, A. N. (2023). Estimating the hospital costs of care for people living with HIV in England using routinely collected data. HIV Medicine. https://doi.org/10.1111/hiv.13529
Vancouver
Miners A, Lampe FC, Cambiano V, Schwenk A, Rodger A, Sadique Z, et al. Estimating the hospital costs of care for people living with HIV in England using routinely collected data. HIV Medicine. 2023. doi:10.1111/hiv.13529
BibTeX
@article{Miners2023,
author = {Miners, Alec and Lampe, Fiona C and Cambiano, Valentina and Schwenk, Achim and Rodger, Alison and Sadique, Zia and Rein, Sophia and Delpech, Valerie and Phillips, Andrew N},
title = {Estimating the hospital costs of care for people living with HIV in England using routinely collected data},
journal = {HIV Medicine},
year = {2023},
doi = {10.1111/hiv.13529}
}
EUVIMED